Trial Outcomes & Findings for Effectiveness of Telemedicine Home Assessments for Identification and Reduction of Asthma Triggers (NCT NCT04896502)

NCT ID: NCT04896502

Last Updated: 2024-10-17

Results Overview

Comparison of D. pteronyssinus levels collected in participant homes at baseline and at end of study with measure of number of subjects with a significant change

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

27 participants

Primary outcome timeframe

4 months

Results posted on

2024-10-17

Participant Flow

Participant milestones

Participant milestones
Measure
Telemedicine Arm
For the proposed study, participants will randomized to receive TM home assessments/interventions performed by a trained home visitor (HV) or standard of care asthma trigger education by the HV. Those who are randomized to TM home assessments/interventions will complete a baseline home assessment and two follow-up visits, 2 months apart. Visits will assess the presence of potential asthma triggers in the home and frequency of asthma symptoms/exacerbations. TM participants will be provided education and materials necessary to reduce asthma triggers in the home. Follow-up visits will assess the interval change in presence of asthma triggers, change in daily asthma symptoms/exacerbations, and participant/family retention of education. Interactive Video (IAV) Telemedicine: Interactive video assessment of asthma triggers in the home.
Standard of Care Education
For subjects randomized to receive standard of care asthma education, written and verbal information will be provided regarding identification and removal of potential asthma triggers in the home but no formal assessment of the home will be performed, nor will participants in this arm receive trigger reduction materials. Standard of Care Education: Education regarding recognition and removal of in-home asthma triggers
Overall Study
STARTED
13
14
Overall Study
COMPLETED
3
4
Overall Study
NOT COMPLETED
10
10

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Effectiveness of Telemedicine Home Assessments for Identification and Reduction of Asthma Triggers

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Telemedicine Arm
n=13 Participants
For the proposed study, participants will randomized to receive TM home assessments/interventions performed by a trained home visitor (HV) or standard of care asthma trigger education by the HV. Those who are randomized to TM home assessments/interventions will complete a baseline home assessment and two follow-up visits, 2 months apart. Visits will assess the presence of potential asthma triggers in the home and frequency of asthma symptoms/exacerbations. TM participants will be provided education and materials necessary to reduce asthma triggers in the home. Follow-up visits will assess the interval change in presence of asthma triggers, change in daily asthma symptoms/exacerbations, and participant/family retention of education. Interactive Video (IAV) Telemedicine: Interactive video assessment of asthma triggers in the home.
Standard of Care Education
n=14 Participants
For subjects randomized to receive standard of care asthma education, written and verbal information will be provided regarding identification and removal of potential asthma triggers in the home but no formal assessment of the home will be performed, nor will participants in this arm receive trigger reduction materials. Standard of Care Education: Education regarding recognition and removal of in-home asthma triggers
Total
n=27 Participants
Total of all reporting groups
Age, Categorical
<=18 years
13 Participants
n=5 Participants
14 Participants
n=7 Participants
27 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
11.52 years
STANDARD_DEVIATION 3.27 • n=5 Participants
8.76 years
STANDARD_DEVIATION 3.59 • n=7 Participants
10.14 years
STANDARD_DEVIATION 3.7 • n=5 Participants
Sex: Female, Male
Female
7 Participants
n=5 Participants
5 Participants
n=7 Participants
12 Participants
n=5 Participants
Sex: Female, Male
Male
6 Participants
n=5 Participants
9 Participants
n=7 Participants
15 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
11 Participants
n=5 Participants
10 Participants
n=7 Participants
21 Participants
n=5 Participants
Race (NIH/OMB)
White
2 Participants
n=5 Participants
3 Participants
n=7 Participants
5 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
13 participants
n=5 Participants
14 participants
n=7 Participants
27 participants
n=5 Participants

PRIMARY outcome

Timeframe: 4 months

Comparison of D. pteronyssinus levels collected in participant homes at baseline and at end of study with measure of number of subjects with a significant change

Outcome measures

Outcome measures
Measure
Telemedicine Arm
n=3 Participants
For the proposed study, participants will randomized to receive TM home assessments/interventions performed by a trained home visitor (HV) or standard of care asthma trigger education by the HV. Those who are randomized to TM home assessments/interventions will complete a baseline home assessment and two follow-up visits, 2 months apart. Visits will assess the presence of potential asthma triggers in the home and frequency of asthma symptoms/exacerbations. TM participants will be provided education and materials necessary to reduce asthma triggers in the home. Follow-up visits will assess the interval change in presence of asthma triggers, change in daily asthma symptoms/exacerbations, and participant/family retention of education. Interactive Video (IAV) Telemedicine: Interactive video assessment of asthma triggers in the home.
Standard of Care Education
n=4 Participants
For subjects randomized to receive standard of care asthma education, written and verbal information will be provided regarding identification and removal of potential asthma triggers in the home but no formal assessment of the home will be performed, nor will participants in this arm receive trigger reduction materials. Standard of Care Education: Education regarding recognition and removal of in-home asthma triggers
Number of Subjects With a Significant Change in D. Pteronyssinus Levels at End of Study Evaluation
0 Participants
0 Participants

SECONDARY outcome

Timeframe: 6 months

We will measure differences in ACT scores from baseline to 6 months between the Telemedicine and Standard of Care groups. Asthma Control Test (ACT) is a 5 question (\<12 years of age) or 7 question (\>/= 12 years of age) test utilized to assess asthma control. Scores range from 0 to 25. The maximum score is 25 and a score of 19 or less indicates "not well-controlled" asthma.

Outcome measures

Outcome measures
Measure
Telemedicine Arm
n=3 Participants
For the proposed study, participants will randomized to receive TM home assessments/interventions performed by a trained home visitor (HV) or standard of care asthma trigger education by the HV. Those who are randomized to TM home assessments/interventions will complete a baseline home assessment and two follow-up visits, 2 months apart. Visits will assess the presence of potential asthma triggers in the home and frequency of asthma symptoms/exacerbations. TM participants will be provided education and materials necessary to reduce asthma triggers in the home. Follow-up visits will assess the interval change in presence of asthma triggers, change in daily asthma symptoms/exacerbations, and participant/family retention of education. Interactive Video (IAV) Telemedicine: Interactive video assessment of asthma triggers in the home.
Standard of Care Education
n=4 Participants
For subjects randomized to receive standard of care asthma education, written and verbal information will be provided regarding identification and removal of potential asthma triggers in the home but no formal assessment of the home will be performed, nor will participants in this arm receive trigger reduction materials. Standard of Care Education: Education regarding recognition and removal of in-home asthma triggers
Differences in ACT Score Between Telemedicine and Standard of Care Groups
Enrollment ACT score
23.3 score on a scale
Standard Deviation 2.36
21.25 score on a scale
Standard Deviation 2.165
Differences in ACT Score Between Telemedicine and Standard of Care Groups
6 Month ACT score
23.3 score on a scale
Standard Deviation 2.36
22 score on a scale
Standard Deviation 3

SECONDARY outcome

Timeframe: 6 months

Patient satisfaction measured by standardized survey. Respondents were asked "How satisfied were you with your overall experience?" and were scored on a scale from "Complete Satisfied" to "Not at All Satisfied"

Outcome measures

Outcome measures
Measure
Telemedicine Arm
n=8 Participants
For the proposed study, participants will randomized to receive TM home assessments/interventions performed by a trained home visitor (HV) or standard of care asthma trigger education by the HV. Those who are randomized to TM home assessments/interventions will complete a baseline home assessment and two follow-up visits, 2 months apart. Visits will assess the presence of potential asthma triggers in the home and frequency of asthma symptoms/exacerbations. TM participants will be provided education and materials necessary to reduce asthma triggers in the home. Follow-up visits will assess the interval change in presence of asthma triggers, change in daily asthma symptoms/exacerbations, and participant/family retention of education. Interactive Video (IAV) Telemedicine: Interactive video assessment of asthma triggers in the home.
Standard of Care Education
n=9 Participants
For subjects randomized to receive standard of care asthma education, written and verbal information will be provided regarding identification and removal of potential asthma triggers in the home but no formal assessment of the home will be performed, nor will participants in this arm receive trigger reduction materials. Standard of Care Education: Education regarding recognition and removal of in-home asthma triggers
Patient Satisfaction
Completely satisfied
4 Participants
4 Participants
Patient Satisfaction
Very satisfied
2 Participants
1 Participants
Patient Satisfaction
Somewhat satisfied
0 Participants
0 Participants
Patient Satisfaction
Not at all satisfied
0 Participants
0 Participants
Patient Satisfaction
Missing data
2 Participants
4 Participants

Adverse Events

Telemedicine Arm

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Standard of Care Education

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Robbie Pesek, MD

Arkansas Children's Hospital

Phone: 501-364-3149

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place